dc.contributor.author | Maharramov, Abel | |
dc.contributor.author | Kaya, Ruya | |
dc.contributor.author | Taslimi, Parham | |
dc.contributor.author | Kurbanova, Malahat | |
dc.contributor.author | Sadigova, Arzu | |
dc.contributor.author | Farzaliyev, Vagif | |
dc.contributor.author | Sujayev, Afsun | |
dc.contributor.author | Gulçin, İlhami | |
dc.date.accessioned | 2019-04-29T08:33:27Z | |
dc.date.available | 2019-04-29T08:33:27Z | |
dc.date.issued | 2019-02 | |
dc.identifier.uri | http://hdl.handle.net/11772/1130 | |
dc.description.abstract | In the presence of chiral organic catalysts, the optically active 4H-chromine was synthesized from the multicomponent condensation of 5,5-dimethylcyclohexane-1,3-dione with malononitrile and methylene-active compound, and the specific angle of rotation of the compounds was determined in the AUTOPOL-III polarimeter and their structures were confirmed by the X-ray spectroscopic analysis method. These optically active 2-amino-4-aryl-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromen-3-carbonitriles were effective inhibitors of alpha-glycosidase, the cytosolic carbonic anhydrase I and II isoforms (hCA I and II), and acetylcholinesterase (AChE) enzymes with K-i values in the range of 21.33 +/- 1.11 to 40.24 +/- 10.78 mu M for hCA I, 28.91 +/- 6.51 to 59.97 +/- 15.62 mu M for hCA II, 18.16 +/- 3.18 to 66.57 +/- 1.36 mu M for alpha-glycosidase, and 8.68 +/- 0.93 to 102.61 +/- 24.96 mu M for AChE. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Wiley | en_US |
dc.relation.isversionof | 10.1002/ardp.201800317 | en_US |
dc.rights | info:eu-repo/semantics/restrictedAccess | en_US |
dc.subject | Antidiabetic potential | en_US |
dc.subject | Asymmetric synthesis | en_US |
dc.subject | Carbonic anhydrase | en_US |
dc.subject | Metabolic enzymes | en_US |
dc.subject | Optically active 4H-chromenes | en_US |
dc.title | Synthesis, crystal structure, and biological evaluation of optically active 2‐amino‐4‐aryl‐7,7‐dimethyl‐5‐oxo‐5,6,7,8‐tetrahydro‐4H‐chromen‐3‐carbonitriles: Antiepileptic, antidiabetic, and anticholinergics potentials | en_US |
dc.type | article | en_US |
dc.relation.journal | Archiv der Pharmazie | en_US |
dc.contributor.department | Bartın Üniversitesi, Fen Fakültesi, Biyoteknoloji Bölümü | en_US |
dc.identifier.volume | 352 | en_US |
dc.identifier.startpage | e1800317 | en_US |